Synthase Inhibitor FAS20013 FASgen Inc. / Johnson & Johnson / Chiron Corporation / Translocase I Inhibitors Sequella Inc. / Wellcome Trust / Moxifloxacin Bayer Pharmaceuticals / Lupin Ltd. / Sequella Inc. / Strategic Plan Stop TB Partnership Working Group / Sankyo / Stop TB Partnership / GlaxoSmithKline / The Working Group / Methyltransferase Inhibitors Anacor Pharmaceuticals / Drug R&D / AstraZeneca / /
Currency
pence / USD / /
Event
FDA Phase / /
Facility
University of Tennessee / Cell Wall Inhibitors Colorado State University / Quinolones KRICT/ Yonsei University / University of Auckland / Cornell University / Novartis Institute / Wellesley College / Global TB Drug Pipeline / Johns Hopkins University / University of Illinois at Chicago / /
IndustryTerm
AIDS therapies / food / HIV treatment / chemical entities / sound infrastructure / /
MedicalCondition
TB / active TB disease / HIV / M. tuberculosis / disease / Mycobacterium tuberculosis / active TB / latent TB infection / HIV/AIDS / latent disease / tuberculosis / /
MedicalTreatment
antibiotics / innovative therapies / combination drug therapy / /
Organization
National Institute of Health / World Health Organization / TB Alliance / Johns Hopkins University / Yonsei University / University of Illinois at Chicago / University of Tennessee / Macrolides TB Alliance / California State Univ. / Cornell University / Colorado State University / European Commission / Wellesley College / Tuberculosis Research Centre / Carboxylates TB Alliance / Novartis Institute for Tropical Diseases / University of Auckland / /
Product
isoniazid / gatifloxacin / TB drug / /
ProgrammingLanguage
EC / /
ProvinceOrState
Illinois / Tennessee / California / Colorado / /
Region
sub-Saharan Africa / /
Technology
combinatorial chemistry / drug discovery / rational drug design / Drug Development / /
Strategic Plan Stop TB Partnership Working Group on New TB Drugs ● ● ●